Renovo Biosciences
2001
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
1
INVESTORS
Description
Provider of a drug discovery platform designed to offer treatment for multiple sclerosis. The company's platform uncover novel neuroregenerative therapies, enabling healthcare providers to cure their patients.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
- 10000 Cedar Avenue
- Cleveland, OH 44106
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Renovo Biosciences’s full profile, request a free trial.
Renovo Biosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | Completed | Startup |
Renovo Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Notox Technologies | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |